We are live on ! Find out more
VIE

Viela Bio, Inc. Common Stock
VIE

Delisted

VIE was delisted on the 12th of March, 2021.

0 hedge funds and large institutions have $0 invested in Viela Bio, Inc. Common Stock in 2021 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 65 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% less funds holding

Funds holding: 650 (-65)

100% less funds holding in top 10

Funds holding in top 10: 10 (-1)

100% less capital invested

Capital invested by funds: $962M → $0 (-$962M)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 65

Holders
Holders Change
-65
Holders Change %
-100%
% of All Funds
Holding in Top 10
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
New
Increased
Reduced
Closed
65
Calls
Puts
Net Calls
Net Calls Change

VIE Hedge Fund Activity: Q1 2021 in Review

0 of the 5,696 institutional investors tracked by Wall St. Rank reported a position in Viela Bio, Inc. Common Stock (VIE) for Q1 2021, worth a combined $0 — down 100% from $962M a quarter earlier.

Sellers outnumbered buyers: 65 funds closed out of VIE and 0 opened new positions — a net loss of 65 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was Fidelity Investments, exiting entirely with an estimated $290M sold.

  • 0 institutional investors held Viela Bio, Inc. Common Stock (VIE) as of Q1 2021, down from 65 in Q4 2020.
  • Funds reported $0 of Viela Bio, Inc. Common Stock stock for Q1 2021, down 100% quarter-over-quarter.
  • 0 funds opened new Viela Bio, Inc. Common Stock positions in Q1 2021 and 65 closed out, a net change of -65 holders.
  • The largest Viela Bio, Inc. Common Stock seller in Q1 2021 was Fidelity Investments, an estimated $290M sold.

Based on aggregated 13F filings for Q1 2021.